Triumeq and Crixivan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triumeq (abacavir sulfate; dolutegravir sodium; lamivudine) and Crixivan (indinavir sulfate). Common drug interactions include osteopenia among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Triumeq and Crixivan. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Triumeq?

Triumeq has active ingredients of abacavir sulfate; dolutegravir sodium; lamivudine. It is often used in hiv infection. eHealthMe is studying from 6,900 Triumeq users. Check the latest studies of Triumeq.

What is Crixivan?

Crixivan has active ingredients of indinavir sulfate. eHealthMe is studying from 6,312 Crixivan users. Check the latest studies of Crixivan.

On Jul, 13, 2026

72 people who take Triumeq and Crixivan together, and have interactions are studied.

What are the common drug interactions of Triumeq and Crixivan, by gender? *:

female:

Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Gait disturbance
Renal failure (kidney dysfunction)
Bone loss
Osteonecrosis (death of bone)
Bone density decreased
Renal injury (kidney injury)
Wrist fracture
Back pain

male:

Emotional distress
Pain
Renal failure (kidney dysfunction)
Fatigue (feeling of tiredness)
Blood creatinine increased
Mobility decreased (ability to move is reduced)
Bone loss
Gait disturbance
Renal injury (kidney injury)
Decreased activity

What are the common drug interactions of Triumeq and Crixivan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Renal failure (kidney dysfunction)
Bone density decreased
Bone loss
Renal impairment (severely reduced kidney function)
Nephrolithiasis (calculi in the kidneys)
Decreased activity
Depression
Dysstasia (difficulty in standing)
Fatigue (feeling of tiredness)
Loose tooth

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Pain
Chronic kidney disease
Depression
Osteopenia (a condition where bone mineral density is lower than normal)
Bone density decreased
Foot fracture
Renal failure (kidney dysfunction)

60+:

Chronic kidney disease
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Blood creatinine increased
Feeling of despair
Foot fracture
Gait disturbance
Insomnia (sleeplessness)
Joint swelling
Ligament rupture (tear in ligament)
Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)

What are the existing conditions these people have? *

Pain: 8 people, 11.11%
Hypersensitivity: 7 people, 9.72%
Stress And Anxiety: 5 people, 6.94%
Cough: 5 people, 6.94%
Rashes (redness): 4 people, 5.56%
High Blood Pressure: 4 people, 5.56%
High Blood Cholesterol: 4 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Triumeq and Crixivan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously